Labelling of aminomethylenephosphonate derivatives with generator- produced 188Re, and a study of their stability

Applied Radiation and Isotopes

Volumn 51, Issue 3, 1999, Pages 307-313

  Hashimoto, Kazuyuki ^a  

^a JAPAN ATOMIC ENERGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DERIVATIVES; PH EFFECTS; RADIOISOTOPES; RHENIUM; SODIUM CHLORIDE; THERMAL EFFECTS;

CARRIER-FREE RADIOISOTOPES;

PHOSPHORUS COMPOUNDS;

ETHYLENEDIAMINE N,N' BIS(METHYLENEPHOSPHONIC ACID); ETHYLENEDIAMINE N,N,N',N' TETRAKIS(METHYLENEPHOSPHONIC ACID); NITRILOTRIS(METHYLENEPHOSPHONIC ACID); RADIOPHARMACEUTICAL AGENT; RHENIUM COMPLEX; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; DILUTION; DRUG STRUCTURE; ISOTOPE LABELING; PH; PRIORITY JOURNAL; TEMPERATURE;

EID: 0032990515     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(99)00047-0     Document Type: Article

References (20)

1. Alberts A.S., Brighton S.W., Kempff P., Louw W.K., Beek A.V., Kritzinger V., Westerink H.P., van Rensburg A.J. Samarium-153-EDTMP for palliation of ankylosing spondylitis, paget's disease and rheumatoid arthritis. J. Nucl. Med. 36:1995;1417.
2. 186Re complex of 1-hydroxyethylidene-1,1-diphosphonate for treatment of painful osseous metastases Radioisotopes. 44:1995;514.
3. 186Re (Sn)-HEDP J. Radioanal. Nucl. Chem. Artic. 206:1996;43.
4. Callahan A.P., Rice D.E., Knapp F.F. Jr. Rhenium-188 for therapeutic applications from an alumina-based tungsten-188/rhenium-188 radionuclide generator. NucCompact. 20:1989;3.
5. De Klerk J.M.H., Van het Schip A.D., Zonnenberg B.A., Van Dijk A., Stokkel M.P.M., Han S.H., Blijham G.H., Van Rijk P.P. Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations. J. Nucl. Med. 35:1994;1423.
6. Deutsch E., Libson K., Vanderheyden J.-L., Ketring A.R., Maxon H.R. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Nucl. Med. Biol. 13:1986;465.
7. 186Re -perrhenate for nuclear medical purposes Int. J. Appl. Radiat. Isot. 33:1982;99.
8. Goeckeler W.F., Edwards B., Volkert W.A., Holmes R.A., Simon J., Wilson D. Skeletal localization of samarium-153 chelates: potential therapeutic bone agents. J. Nucl. Med. 28:1987;495.
9. 188Re Appl. Radiat. Isot. 47:1996;195.
10. 188Re . JAERI-Conf 97-003 (Proc. of the 7th Int. Sym. on Advanced Nuclear Energy Research). 1997;313.
11. 188Re , and a study of its stability Appl. Radit. Isot. 49:1998;351.
12. Lattimer J.C., Corwin L.A. Jr., Stapleton J., Volkert W.A., Ehrhardt G.J., Ketring A.R., Anderson S.K., Simon J., Goeckeler W.F. Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP. J. Nucl. Med. 31:1990;1316.
13. 153Sm in rats Appl. Radiat. Isot. 45:1994;949.
14. Lewington V.J. Targeted radionuclide therapy for bone metastases. Eur. J. Nucl. Med. 20:1993;66.
15. Mathieu L., Chevalier P., Galy G., Berger M. Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms. Int. J. Appl. Radiat. Isot. 30:1979;725.
16. Mausner L.F., Srivastava S.C. Selection of radionuclides for radioimmunotherapy. Med. Phys. 20:1993;503.
17. Maxon H.R. III, Schroder L.E., Hertzberg V.S., Thomas S.R., Englaro E.E., Samaratunga R., Smith H., Moulton J.S., Williams C.C., Ehrhardt G.J., Schneider H.J. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. J. Nucl. Med. 32:1991;1877.
18. Singh A., Holmes R.A., Farhangi M., Volkert W.A., Williams A., Stringham L.M., Ketring R. Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer. J. Nucl. Med. 30:1989;1814.
19. Vera-Ruiz H. Radiopharmaceuticals as therapeutic agents in medical care and treatment. IAEA Bull. 35:1993;24.
20. 99mTc -diagnostic agents Appl. Radiat. Isot. 38:1987;283.